640 related articles for article (PubMed ID: 19421811)
21. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
22. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Akiba S; Aikou T
Br J Surg; 2001 Jul; 88(7):988-93. PubMed ID: 11442533
[TBL] [Abstract][Full Text] [Related]
23. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
24. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
25. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
[TBL] [Abstract][Full Text] [Related]
28. [Total pelvic exenteration in the treatment of advanced pelvic cancer].
Mitulescu G; Ungureanu C; Gluck G; Stîngu C; Mitulescu D; Stănculeanu D; Sgarbură O; Tulbure D; Popescu I
Chirurgia (Bucur); 2007; 102(2):143-54. PubMed ID: 17615915
[TBL] [Abstract][Full Text] [Related]
29. Management of advanced pelvic cancer by exenteration.
Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies.
Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M
Tech Coloproctol; 2023 Dec; 27(12):1367-1375. PubMed ID: 37878167
[TBL] [Abstract][Full Text] [Related]
31. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
32. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
[TBL] [Abstract][Full Text] [Related]
33. Sacral resection for control of pelvic tumors.
Temple WJ; Ketcham AS
Am J Surg; 1992 Apr; 163(4):370-4. PubMed ID: 1373043
[TBL] [Abstract][Full Text] [Related]
34. [Total pelvic exenteration].
Heger U; Koch M; Büchler MW; Weitz J
Chirurg; 2010 Oct; 81(10):897-901. PubMed ID: 20835694
[TBL] [Abstract][Full Text] [Related]
35. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
PelvEx Collaborative
Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
37. The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival.
Spahn M; Weiss C; Bader P; Frohneberg D; Studer UE; Burkhard FC
Urol Int; 2010; 85(1):16-22. PubMed ID: 20299775
[TBL] [Abstract][Full Text] [Related]
38. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
39. Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Gallotta V; Margariti AP; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):880-4. PubMed ID: 24685828
[TBL] [Abstract][Full Text] [Related]
40. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer.
Wiig JN; Poulsen JP; Larsen S; Braendengen M; Waehre H; Giercksky KE
Eur J Surg; 2002; 168(1):42-8. PubMed ID: 12022371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
